CorMatrix Cardiovascular Receives FDA Approval to Expand and Enroll 20 Additional Patients in the Adult Arm of its Early Feasibility IDE study of the Cor® TRICUSPID ECM® Valve for Pediatric and Adult Patientsnews2024-01-26T08:44:17+00:00January 26th, 2024|Medical Device News Magazine|
